'Incredible Colon' to march across the state in Colon Cancer Awareness Month; more than a dozen stops scheduled

A special tour throughout the state of the Incredible Colon — an inflatable model of a human colon, large enough for visitors to walk through it — will promote education about risks and preventive measures of colon cancer during March, National Colon Cancer Awareness Month.

Colon cancer is the second leading cause of cancer mortality in Kentucky and nationwide, and it affects men and women of all ethnicities. Kentuckians have a higher than average risk of colon cancer due to higher rates of obesity, diets high in fat, and lack of regular exercise.

As many as 60 percent of deaths from colorectal cancer could be prevented if everyone age 50 and older were screened regularly, according to the federal Centers for Disease Control and Prevention. Screenings detect any abnormalities or early signs of cancer, like polyps in the colon, and when detected early, polyps can be easily removed during a colonoscopy before they develop into cancer. When colon cancer is found early and treated, the five-year relative survival rate is 90 percent, underscoring the need for preventive health exams.

However, only 63 percent of Kentuckians who should have screening tests have had them, according to Kentucky data from the federal Behavioral Risk Factor Surveillance System, an ongoing national survey.

The colon tour is a coordinated promotion by the Kentucky Cancer Program, local cancer councils and the Kentucky Colon Cancer Prevention Project. It is free and open to the public and will take place in 13 Kentucky communities March 4-28:

• March 4: Fleming County Hospital, Flemingsburg (10:30 a.m. - 2:30 p.m.)
• March 5: Walmart, Manchester (Noon - 4 p.m.)
• March 6: Hazard ARH Medical Mall, Hazard (10 a.m. - 3 p.m.)
• March 7: Rowan County Chamber of Commerce, Morehead (members
  only, 9:30 a.m. - 3 p.m.)
• March 8: Frankfort Regional Hospital, Frankfort (9 a.m. - 4 p.m.)
• March 19: Lexmark, Lexington, (Employees only, 8:30 a.m. - 2 p.m.)
• March 20: Lawrence County High School, Louisa (8 a.m. - 5 p.m.)
• March 21: Lady of Bellefonte Health Center, Grayson (10 a.m. - 2 p.m.)
• March 23: Phillip Sharp Middle School, Butler (8-11 a.m. )
• March 25: Town Center Mall, Ashland (10 a.m. - 3 p.m.)
• March 26: Walmart, Georgetown (3-6 p.m.)
• March 27: Adron Doran University Center, Morehead (9:30 a.m. - 3 p.m.)
• March 28: Walmart, Somerset (10 a.m. - 2 p.m.)

Attendees are invited to dress in blue, the color of colon cancer awareness, and there will be door prizes, giveaways (while supplies last), refreshments and educational information about colon cancer screening, prevention and early detection. (Read more)

A special tour throughout the state of the Incredible Colon — an inflatable model of a human colon, large enough for visitors to walk through it — will promote education about risks and preventive measures of colon cancer during March, National Colon Cancer Awareness Month.

Colon cancer is the second leading cause of cancer mortality in Kentucky and nationwide, and it affects men and women of all ethnicities. Kentuckians have a higher than average risk of colon cancer due to higher rates of obesity, diets high in fat, and lack of regular exercise.

As many as 60 percent of deaths from colorectal cancer could be prevented if everyone age 50 and older were screened regularly, according to the federal Centers for Disease Control and Prevention. Screenings detect any abnormalities or early signs of cancer, like polyps in the colon, and when detected early, polyps can be easily removed during a colonoscopy before they develop into cancer. When colon cancer is found early and treated, the five-year relative survival rate is 90 percent, underscoring the need for preventive health exams.

However, only 63 percent of Kentuckians who should have screening tests have had them, according to Kentucky data from the federal Behavioral Risk Factor Surveillance System, an ongoing national survey.

The colon tour is a coordinated promotion by the Kentucky Cancer Program, local cancer councils and the Kentucky Colon Cancer Prevention Project. It is free and open to the public and will take place in 13 Kentucky communities March 4-28:

• March 4: Fleming County Hospital, Flemingsburg (10:30 a.m. - 2:30 p.m.)
• March 5: Walmart, Manchester (Noon - 4 p.m.)
• March 6: Hazard ARH Medical Mall, Hazard (10 a.m. - 3 p.m.)
• March 7: Rowan County Chamber of Commerce, Morehead (members
  only, 9:30 a.m. - 3 p.m.)
• March 8: Frankfort Regional Hospital, Frankfort (9 a.m. - 4 p.m.)
• March 19: Lexmark, Lexington, (Employees only, 8:30 a.m. - 2 p.m.)
• March 20: Lawrence County High School, Louisa (8 a.m. - 5 p.m.)
• March 21: Lady of Bellefonte Health Center, Grayson (10 a.m. - 2 p.m.)
• March 23: Phillip Sharp Middle School, Butler (8-11 a.m. )
• March 25: Town Center Mall, Ashland (10 a.m. - 3 p.m.)
• March 26: Walmart, Georgetown (3-6 p.m.)
• March 27: Adron Doran University Center, Morehead (9:30 a.m. - 3 p.m.)
• March 28: Walmart, Somerset (10 a.m. - 2 p.m.)

Attendees are invited to dress in blue, the color of colon cancer awareness, and there will be door prizes, giveaways (while supplies last), refreshments and educational information about colon cancer screening, prevention and early detection. (Read more)

Read More

Avoid virus-linked cancers, including cervical cancer, with shots

With a simple vaccine, you can avoid HPV-linked cancer, including cervical cancer and many cancers of the mouth, throat, anus and genitals, which constitute more than 3 percent of all U.S. cancer diagnoses. Vaccination against the human papilloma virus (HPV) thwarts the virus’s spread, wrecks its ability to jump between people and inhibits a virus that in 2009 led to a cancer diagnosis for 30,000 people in the U.S., according to the National Cancer Insititue. 

HPV infection is common. More than half of women between 14 and 59 catch a genital HPV. Many of these infections are low-risk, but when the body does not sweep out HPV intruders, high-risk HPV infected cells may lead to the unchecked growth of cancerous cells, according to Newswise, a research-reporting service.

HPV is actually a family of more than 150 viruses that infect human skin and mucosa, the moist membranes lining the nostrils, mouth and genital cavities. Two vaccines, Gardasil and Cervarix, prevent people from getting HPV infections by helping the body stockpile a medley of cellular defenses. Gardasil and Cervarix target HPV types 16 and 18, the two responsible for most cervical, anal, genital, and oropharynx cancer.  Blocking infection by types 16 and 18 also fights off other cancers, and the vaccines’ protection could last a lifetime. Gardasil also targets types 6 and 11.

It is important to complete the three-dose series for the vaccines; series completion rates are low for people in the Southern states, especially those that are poor and without private insurance, according to Newswise. Scientists are working to make a single vaccine that blocks infection by all HPV types, but today’s vaccines can prevent infection by two of the most common high-risk HPVs and may be the first step toward preventing HPV-linked cancers. (Read more)

With a simple vaccine, you can avoid HPV-linked cancer, including cervical cancer and many cancers of the mouth, throat, anus and genitals, which constitute more than 3 percent of all U.S. cancer diagnoses. Vaccination against the human papilloma virus (HPV) thwarts the virus’s spread, wrecks its ability to jump between people and inhibits a virus that in 2009 led to a cancer diagnosis for 30,000 people in the U.S., according to the National Cancer Insititue. 

HPV infection is common. More than half of women between 14 and 59 catch a genital HPV. Many of these infections are low-risk, but when the body does not sweep out HPV intruders, high-risk HPV infected cells may lead to the unchecked growth of cancerous cells, according to Newswise, a research-reporting service.

HPV is actually a family of more than 150 viruses that infect human skin and mucosa, the moist membranes lining the nostrils, mouth and genital cavities. Two vaccines, Gardasil and Cervarix, prevent people from getting HPV infections by helping the body stockpile a medley of cellular defenses. Gardasil and Cervarix target HPV types 16 and 18, the two responsible for most cervical, anal, genital, and oropharynx cancer.  Blocking infection by types 16 and 18 also fights off other cancers, and the vaccines’ protection could last a lifetime. Gardasil also targets types 6 and 11.

It is important to complete the three-dose series for the vaccines; series completion rates are low for people in the Southern states, especially those that are poor and without private insurance, according to Newswise. Scientists are working to make a single vaccine that blocks infection by all HPV types, but today’s vaccines can prevent infection by two of the most common high-risk HPVs and may be the first step toward preventing HPV-linked cancers. (Read more)

Read More

Breast cancer awareness: Testing urged, guidelines explained, misconceptions explored

Women with BRCA1 and BRCA2, the
genes most commonly involved in breast
cancer, have up to an 80 percent chance
of getting the disease.

October is Breast Cancer Awareness Month. Although Kentucky's breast cancer rate is slightly lower than the nationwide rate, almost 600 women die every year from breast cancer in the Commonwealth. The American Cancer Society predicts approximately 3,160 new cases of breast cancer will be diagnosed in Kentucky this year. Early detection and prompt treatment can significantly reduce suffering and death from the disease.

According to the Cabinet for Health and Family Services, all health plans serving Kentuckians must, by law, cover mammograms. Medical guidelines strongly recommend that women older than 40 have annual mammograms and women younger than 40 with a family history of breast cancer should also have regular screenings. Through local health departments, the Kentucky Women's Cancer Screening Program provides breast cancer screenings, mammograms and Pap tests to eligible women in every county. During the 2011 fiscal year, KWCSP provided breast cancer screenings to 14,212 women. Services are provided to low-income women through the Kentucky Department for Public Health. Those women must be uninsured with incomes less than 250 percent of federal poverty guidelines.  For more information about breast cancer or screening services, call your local health department.

There are many misconceptions about the risks of developing breast cancer. Genetics, of course, is a well-documented factor but lifestyle issues have gotten a lot of talk. So what's true? Wendy Chen, MD, MPH, a breast cancer expert at Dana-Farber Cancer Institute in Boston, a principal teaching affiliate of Harvard University, tackles some of the more common questions here:

1) Soy may increase the risk of breast cancer returning.
False. Chen, who was part of a study that looked at over 9,500 American and Chinese breast cancer survivors who ate soy every day, says that eating soy may be linked to a lower risk of recurrence of breast cancer.

2) Alcohol consumption can increase the risk of breast cancer.
True. Dana-Farber researchers found that women who consume one alcoholic drink a day may increase their risk for breast cancer.  Chen and her colleagues analyzed data from over 105,000 women in the Nurses’ Health Study. Those who consumed three to six glasses of wine a week were 15 percent more likely to receive a diagnosis of breast cancer. Those who drank fewer than three drinks a week had no increased risk.

3) Fertility treatments increase a woman’s risk of breast cancer.
False. According to a recent study from the National Institutes of Health, ovulation-inducing fertility treatments like Clomid and follicle stimulating hormone (FSH) do not significantly increase a woman's risk of developing breast cancer.

4) Wearing deodorant can increase the risk of breast cancer.
False. According to the National Cancer Institute, there is no conclusive research linking underarm deodorants to breast cancer.

5) The bigger the baby the bigger the risk of getting breast cancer.
Possibly true. “This is a tough one because the research is still evolving,” says Chen. "But the latest research shows that women who have larger babies have more than twice the risk of developing breast cancer than mothers who give birth to smaller infants. Researchers say that having a heavier baby may create a hormonal environment in pregnancy that could lead to the future development of breast cancer. They found that during pregnancy in women who have heavier babies, the ratio of estrogen to anti-estrogen is unusually high. The greater the level of estrogen, the higher the risk of breast cancer. However, Chen emphasizes, women who have larger babies should not panic. There is definitely a need for further research.” (Read more)

Women with BRCA1 and BRCA2, the
genes most commonly involved in breast
cancer, have up to an 80 percent chance
of getting the disease.

October is Breast Cancer Awareness Month. Although Kentucky's breast cancer rate is slightly lower than the nationwide rate, almost 600 women die every year from breast cancer in the Commonwealth. The American Cancer Society predicts approximately 3,160 new cases of breast cancer will be diagnosed in Kentucky this year. Early detection and prompt treatment can significantly reduce suffering and death from the disease.

According to the Cabinet for Health and Family Services, all health plans serving Kentuckians must, by law, cover mammograms. Medical guidelines strongly recommend that women older than 40 have annual mammograms and women younger than 40 with a family history of breast cancer should also have regular screenings. Through local health departments, the Kentucky Women's Cancer Screening Program provides breast cancer screenings, mammograms and Pap tests to eligible women in every county. During the 2011 fiscal year, KWCSP provided breast cancer screenings to 14,212 women. Services are provided to low-income women through the Kentucky Department for Public Health. Those women must be uninsured with incomes less than 250 percent of federal poverty guidelines.  For more information about breast cancer or screening services, call your local health department.

There are many misconceptions about the risks of developing breast cancer. Genetics, of course, is a well-documented factor but lifestyle issues have gotten a lot of talk. So what's true? Wendy Chen, MD, MPH, a breast cancer expert at Dana-Farber Cancer Institute in Boston, a principal teaching affiliate of Harvard University, tackles some of the more common questions here:

1) Soy may increase the risk of breast cancer returning.
False. Chen, who was part of a study that looked at over 9,500 American and Chinese breast cancer survivors who ate soy every day, says that eating soy may be linked to a lower risk of recurrence of breast cancer.

2) Alcohol consumption can increase the risk of breast cancer.
True. Dana-Farber researchers found that women who consume one alcoholic drink a day may increase their risk for breast cancer.  Chen and her colleagues analyzed data from over 105,000 women in the Nurses’ Health Study. Those who consumed three to six glasses of wine a week were 15 percent more likely to receive a diagnosis of breast cancer. Those who drank fewer than three drinks a week had no increased risk.

3) Fertility treatments increase a woman’s risk of breast cancer.
False. According to a recent study from the National Institutes of Health, ovulation-inducing fertility treatments like Clomid and follicle stimulating hormone (FSH) do not significantly increase a woman's risk of developing breast cancer.

4) Wearing deodorant can increase the risk of breast cancer.
False. According to the National Cancer Institute, there is no conclusive research linking underarm deodorants to breast cancer.

5) The bigger the baby the bigger the risk of getting breast cancer.
Possibly true. “This is a tough one because the research is still evolving,” says Chen. "But the latest research shows that women who have larger babies have more than twice the risk of developing breast cancer than mothers who give birth to smaller infants. Researchers say that having a heavier baby may create a hormonal environment in pregnancy that could lead to the future development of breast cancer. They found that during pregnancy in women who have heavier babies, the ratio of estrogen to anti-estrogen is unusually high. The greater the level of estrogen, the higher the risk of breast cancer. However, Chen emphasizes, women who have larger babies should not panic. There is definitely a need for further research.” (Read more)

Read More